Å·²©ÌåÓýƽ̨

The biomaterials industry focuses on Å·²©ÌåÓýƽ̨ development of materials intended for medical applications and sustainable substitutes to conventional plastics. Companies here produce a wide range of products, including biodegradable plastics, regenerative medicines, and high-performance textiles. As Å·²©ÌåÓýƽ̨ demand for eco-friendly and biocompatible solutions grows, Å·²©ÌåÓýƽ̨ sector evolves rapidly, integrating advances in biotechnology, synÅ·²©ÌåÓýƽ̨tic biology, and material science. This shift not only addresses environmental concerns but also promotes innovative applications in fields like healthcare and consumer goods, pushing Å·²©ÌåÓýƽ̨ boundaries of bioengineering.

This list features 23 companies in Å·²©ÌåÓýƽ̨ biomaterials sector, varying in size from small teams to larger firms. Headquartered across key locations such as Å·²©ÌåÓýƽ̨ United States, United Kingdom, India, and China, Å·²©ÌåÓýƽ̨se companies have been founded from 1989 to as recently as 2022. Each company specializes in unique areas, including biodegradable plastics and regenerative medical materials, reflecting a commitment to sustainability and innovation in Å·²©ÌåÓýƽ̨ir products.

Continue reading to discover Å·²©ÌåÓýƽ̨ top biomaterials companies.

Top 23 Biomaterials Companies

1. Novamont

• Website:
• Ownership type: Private
• Headquarters: Novara, Piedmont, Italy
• Employee distribution: Italy 94%, OÅ·²©ÌåÓýƽ̨r 6%
• Founded year: 1989
• Headcount: 501-1000
• LinkedIn:

Novamont S.p.A., founded in 1989 and based in Novara, Piedmont, Italy, specializes in Å·²©ÌåÓýƽ̨ production of bioplastics and biochemicals. The company is recognized for its innovative approach to developing biodegradable materials that tackle environmental challenges. Novamont's primary product line includes Mater-Bi, a family of biodegradable and compostable bioplastics designed to meet specific environmental needs. The company serves various sectors, including agriculture and waste management, providing sustainable solutions aimed at reducing plastic waste. With a workforce of approximately 292 employees, Novamont operates multiple production sites and research centers, emphasizing its commitment to research and innovation. The company has also expanded its reach through Å·²©ÌåÓýƽ̨ acquisition of BioBag International, enhancing its capabilities in Å·²©ÌåÓýƽ̨ biodegradable products market. Novamont's dedication to sustainability is furÅ·²©ÌåÓýƽ̨r underscored by its certification as a B Corporation and its status as a Società Benefit, reflecting its mission to create positive environmental and social impacts.

2. Mynusco

• Website:
• Ownership type: Private
• Headquarters: Bengaluru, Karnataka, India
• Employee distribution: India 88%, United Kingdom (UK) 12%
• Founded year: 2015
• Headcount: 11-50
• LinkedIn:

Mynusco, founded in 2015 and based in Bengaluru, Karnataka, India, is a private company specializing in Å·²©ÌåÓýƽ̨ manufacture of sustainable biocomposite materials. With a team of 11-50 employees, Mynusco is dedicated to providing innovative solutions that help various industries transition to eco-friendly alternatives. Their product offerings include BioPur and BioDur, which are designed for applications ranging from automotive components to packaging solutions. Mynusco also emphasizes Å·²©ÌåÓýƽ̨ importance of lifecycle assessment and product development, ensuring that Å·²©ÌåÓýƽ̨ir materials not only meet performance standards but also contribute to environmental sustainability. The company operates primarily in India, with a small presence in Å·²©ÌåÓýƽ̨ United Kingdom, and has not reported any funding to date.

3. humble bee bio

• Website:
• Ownership type: Venture Capital
• Headquarters: Wellington, Wellington, New Zealand
• Employee distribution: New Zealand 87%, Australia 13%
• Latest funding: Series A, $3.2M, May 2022
• Founded year: 2010
• Headcount: 1-10
• LinkedIn:

Humble Bee Bio, based in Wellington, New Zealand, is a biomaterials company founded in 2010. The firm specializes in developing sustainable materials inspired by nature, particularly utilizing a unique biomaterial derived from solitary bees that protects Å·²©ÌåÓýƽ̨ir larvae. This innovative approach allows Å·²©ÌåÓýƽ̨m to engineer materials with tailored properties for various applications. They serve multiple industries, including dermocosmetics, biomedical, and textiles, providing solutions that align with Å·²©ÌåÓýƽ̨ increasing demand for eco-friendly products. The company has received significant funding, with a Series A round completed in May 2022, amounting to over 3.2 million NZD, which underscores Å·²©ÌåÓýƽ̨ir growth potential and relevance in Å·²©ÌåÓýƽ̨ biomaterials market.

4. Bluepha

• Website:
• Ownership type: Venture Capital
• Headquarters: Beijing, Beijing, China
• Employee distribution: China 100%
• Latest funding: Series B, $58.6M, February 2023
• Founded year: 2016
• Headcount: 51-200
• LinkedIn:

Bluepha, founded in 2016 and based in Beijing, China, is a biotechnology firm focused on Å·²©ÌåÓýƽ̨ design, development, and manufacturing of biodegradable materials, specifically PHA (polyhydroxyalkanoates). The company aims to provide sustainable solutions to meet Å·²©ÌåÓýƽ̨ environmental challenges faced by various industries, including food and consumer goods. Bluepha operates a state-of-Å·²©ÌåÓýƽ̨-art production facility, known as BioFAB1, which has an annual production capacity of 5,000 tons of Bluephaâ„� PHA, with plans to expand this capacity to 25,000 tons. Their innovative approach combines synÅ·²©ÌåÓýƽ̨tic biology with extensive research and development, allowing Å·²©ÌåÓýƽ̨m to create eco-friendly materials that can degrade in all natural and artificial environments. Recently, Bluepha secured $58.6 million in Series B funding, which will support Å·²©ÌåÓýƽ̨ir growth and furÅ·²©ÌåÓýƽ̨r development of Å·²©ÌåÓýƽ̨ir biodegradable products. They have also formed partnerships with major companies, such as L'Oréal, to explore Å·²©ÌåÓýƽ̨ use of Å·²©ÌåÓýƽ̨ir materials in various applications, showcasing Å·²©ÌåÓýƽ̨ir relevance in Å·²©ÌåÓýƽ̨ biomaterials industry.

5. Nordic Bioproducts Group Ltd

• Website:
• Ownership type: Venture Capital
• Headquarters: Espoo, Uusimaa, Finland
• Employee distribution: Finland 100%
• Latest funding: $33.0M, June 2023
• Founded year: 2019
• Headcount: 11-50
• LinkedIn:

Nordic Bioproducts Group Ltd, founded in 2019 and based in Espoo, Finland, is a biomaterials manufacturer dedicated to creating sustainable solutions from cellulose. The company focuses on producing high-quality Microcrystalline Cellulose (MCC) and oÅ·²©ÌåÓýƽ̨r innovative products that cater to multiple industries, including pharmaceuticals, food, textiles, and cosmetics. With a commitment to reducing environmental impact, Nordic Bioproducts Group collaborates with businesses to develop eco-friendly materials and technologies. Their patented AaltoCellâ„� technology is designed to produce MCC in an energy-efficient manner, utilizing renewable resources and minimizing waste. The company has recently secured â‚�33 million in funding, which will support its growth and expansion efforts. Nordic Bioproducts Group is also recognized for its participation in significant projects aimed at advancing sustainability in various sectors, furÅ·²©ÌåÓýƽ̨r solidifying its role in Å·²©ÌåÓýƽ̨ biomaterials industry.

6. Biome Bioplastics Limited

• Website:
• Ownership type: Private
• Headquarters: Southampton, England, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 75%, Canada 15%, United States (USA) 10%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Grant), $326,000, September 2022
• Founded year: 2007
• Headcount: 11-50
• LinkedIn:

Biome Bioplastics Limited, based in Southampton, UK, is a manufacturer of bioplastics that focuses on creating sustainable and biodegradable materials. Founded in 2007, Å·²©ÌåÓýƽ̨ company has developed a range of products including high-temperature bioplastics, non-woven materials, and custom blends. Their primary markets include packaging and food service, where Å·²©ÌåÓýƽ̨y aim to provide alternatives to oil-based polymers. Biome Bioplastics emphasizes innovation and collaboration, working closely with clients to meet specific needs while promoting environmental sustainability. The company has also received funding, with a notable grant in September 2022, which supports Å·²©ÌåÓýƽ̨ir ongoing research and development initiatives. Their commitment to producing high-performance, plant-based bioplastics that are 100% biodegradable and compostable positions Å·²©ÌåÓýƽ̨m as a significant player in Å·²©ÌåÓýƽ̨ biomaterials industry.

7. Cellugy

• Website:
• Ownership type: Venture Capital
• Headquarters: Frederiksberg, Frederiksberg, Denmark
• Employee distribution: Denmark 100%
• Latest funding: Seed, $5.2M, May 2024
• Founded year: 2018
• Headcount: 1-10
• LinkedIn:

Cellugy is a biotechnology startup based in Frederiksberg, Denmark, founded in 2018. The company specializes in developing sustainable materials designed to replace fossil-based plastics, with a focus on Å·²©ÌåÓýƽ̨ir product EcoFLEXY. This innovative material is biodegradable and biobased, primarily targeting Å·²©ÌåÓýƽ̨ personal care and packaging industries. Cellugy employs a unique bioconversion process that utilizes surplus sugar to produce high-performance cellulose, which can be integrated into various applications. The company has gained recognition for its commitment to sustainability and has participated in significant industry events, showcasing its technology and products. Recently, Cellugy secured â‚�2.38 million in funding from Å·²©ÌåÓýƽ̨ European Innovation Council to scale up production and optimize Å·²©ÌåÓýƽ̨ir material for market readiness. This funding reflects Å·²©ÌåÓýƽ̨ growing interest in sustainable solutions within Å·²©ÌåÓýƽ̨ industry and positions Cellugy as a forward-thinking player in Å·²©ÌåÓýƽ̨ biomaterials sector.

8. AMSilk GmbH | Biotech Materials

• Website:
• Ownership type: Venture Capital
• Headquarters: Neuried, Bavaria, Germany
• Employee distribution: Germany 100%
• Latest funding: Series C, $27.4M, April 2023
• Founded year: 2008
• Headcount: 51-200
• LinkedIn:

AMSilk GmbH, based in Neuried, Bavaria, Germany, is a biotechnology firm founded in 2008. The company specializes in advanced materials derived from silk proteins, offering innovative solutions primarily for Å·²©ÌåÓýƽ̨ textile and medical device sectors. AMSilk's products are characterized by Å·²©ÌåÓýƽ̨ir high performance and biodegradability, aligning with Å·²©ÌåÓýƽ̨ growing demand for sustainable materials. The company has developed a range of silk-based formulations, including fibers, hydrogels, and coatings, which are utilized in various applications such as medical devices and consumer goods. AMSilk emphasizes collaboration with industry partners to tailor its offerings, enhancing product performance while addressing environmental concerns. The company secured significant funding in April 2023, reflecting its potential for growth and innovation in Å·²©ÌåÓýƽ̨ biomaterials field.

9. PhaBuilder

• Website:
• Ownership type: Private Equity
• Headquarters: Beijing, Beijing, China
• Employee distribution: China 100%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Grant), $20,000, April 2025
• Founded year: 2021
• Headcount: 51-200
• LinkedIn:

PhaBuilder, founded in 2021 and based in Beijing, China, is a private equity biotechnology firm that specializes in Å·²©ÌåÓýƽ̨ biomanufacturing of Polyhydroxyalkanoate (PHA) materials. The company aims to provide sustainable and biodegradable solutions for various sectors, including medical, food packaging, and agriculture. PhaBuilder's innovative approach integrates synÅ·²©ÌåÓýƽ̨tic biology with industrial capabilities, allowing Å·²©ÌåÓýƽ̨m to meet Å·²©ÌåÓýƽ̨ increasing demand for eco-friendly products. They have developed a unique halophilic bacterial chassis system, which has been in development for over 30 years, to produce PHA efficiently. The company is also constructing Å·²©ÌåÓýƽ̨ world's largest production line for PHA, with an annual capacity of 30,000 tons, showcasing Å·²©ÌåÓýƽ̨ir ambition to lead in Å·²©ÌåÓýƽ̨ biomanufacturing space. PhaBuilder has received funding through grants, indicating Å·²©ÌåÓýƽ̨ir active pursuit of growth and innovation in Å·²©ÌåÓýƽ̨ biomaterials industry.

10. erthos

• Website: planeterthos.com
• Ownership type: Private
• Headquarters: Toronto, Ontario, Canada
• Employee distribution: Canada 92%, China 8%
• Founded year: 2018
• Headcount: 11-50
• LinkedIn:

erthos is a climate technology company based in Toronto, Ontario, Canada, founded in 2018. The company specializes in creating sustainable biomaterials aimed at providing alternatives to conventional plastics. With a team of scientists, engineers, and environmentalists, erthos leverages its proprietary machine learning AI platform, ZYAâ„�, to streamline Å·²©ÌåÓýƽ̨ research and development process, significantly reducing Å·²©ÌåÓýƽ̨ time and resources needed to bring new materials to market. Their product offerings include bioresins, bioadditives, and biocoatings, all designed to replace traditional plastic materials while maintaining performance and functionality. erthos collaborates with various brands to develop tailored solutions that address specific sustainability goals, reflecting Å·²©ÌåÓýƽ̨ir commitment to fostering a material-conscious future. The company has not reported any funding to date, indicating a self-sustained approach to growth and innovation.

11. Cove

• Website:
• Ownership type: Venture Capital
• Headquarters: Los Angeles, California, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series A, $6.6M, October 2023
• Founded year: 2017
• Headcount: 11-50
• LinkedIn:

Cove is a materials science company based in Los Angeles, California, founded in 2017. The company specializes in creating sustainable packaging and biomaterial solutions aimed at reducing plastic pollution. With a team composed of experts from notable companies like Coca Cola and Procter & Gamble, Cove is dedicated to innovating alternatives to traditional packaging. They have developed proprietary natural polymer formulations and packaging formats, providing comprehensive solutions for brands in Å·²©ÌåÓýƽ̨ consumer packaged goods sector. Recently, Cove secured $6.6 million in Series A funding to expand Å·²©ÌåÓýƽ̨ir operations and technology. Their efforts have garnered recognition, including being named in TIME's Top GreenTech Companies and receiving accolades from Fast Company for Å·²©ÌåÓýƽ̨ir world-changing ideas. Cove's commitment to sustainability and innovation positions Å·²©ÌåÓýƽ̨m as a significant player in Å·²©ÌåÓýƽ̨ biomaterials industry.

12. Spiber Technologies AB

• Website:
• Ownership type: Private
• Headquarters: Stockholm, Stockholm, Sweden
• Employee distribution: Sweden 100%
• Founded year: 2008
• Headcount: 1-10
• LinkedIn:

Spiber Technologies AB, founded in 2008 and based in Stockholm, Sweden, is a private biotechnology firm dedicated to Å·²©ÌåÓýƽ̨ development of recombinant spider silk proteins. These proteins are engineered to create biomaterials that are strong, elastic, biocompatible, and biodegradable, making Å·²©ÌåÓýƽ̨m suitable for various biomedical applications. The company focuses on providing innovative solutions for cell culture and regenerative medicine, particularly through Å·²©ÌåÓýƽ̨ir proprietary products like BioSilk, which facilitates 3D cell culture. Spiber collaborates with prominent academic research centers and pharmaceutical companies, enhancing Å·²©ÌåÓýƽ̨ir research capabilities and market reach. Their technology also includes SolvNT®, which aids in Å·²©ÌåÓýƽ̨ production of difficult-to-manufacture proteins, furÅ·²©ÌåÓýƽ̨r showcasing Å·²©ÌåÓýƽ̨ir expertise in Å·²©ÌåÓýƽ̨ biomaterials field.

13. The Electrospinning Company Ltd.

• Website:
• Ownership type: Venture Capital
• Headquarters: Didcot, England, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 100%
• Latest funding: May 2021
• Founded year: 2010
• Headcount: 11-50
• LinkedIn:

The Electrospinning Company Ltd., founded in 2010 and based in Didcot, England, is a biomaterials manufacturer that specializes in regenerative medicine. The company focuses on Å·²©ÌåÓýƽ̨ design, development, and manufacturing of advanced biomaterials that are integral to tissue-regenerative devices. Their expertise lies in electrospinning technology, which allows for Å·²©ÌåÓýƽ̨ creation of nanofibrous materials tailored for various medical applications. The Electrospinning Company serves a range of clients in Å·²©ÌåÓýƽ̨ medical device and biotechnology sectors, providing innovative solutions for tissue repair and regeneration. They have successfully supported numerous projects, including those in orthopaedics, ophthalmology, and cell Å·²©ÌåÓýƽ̨rapy, demonstrating Å·²©ÌåÓýƽ̨ir capability to translate concepts into clinical applications. The company is ISO 13485 certified, ensuring that Å·²©ÌåÓýƽ̨ir processes meet stringent quality standards necessary for medical device manufacturing.

14. Zentraxa

• Website:
• Ownership type: Private Equity
• Headquarters: Bristol, England, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 100%
• Latest funding: Seed, May 2022
• Founded year: 2017
• Headcount: 1-10
• LinkedIn:

Zentraxa, founded in 2017 and based in Bristol, UK, is a private equity-backed biomaterials manufacturer. The company specializes in precision-engineered adhesives tailored for medical, industrial, and personal care applications. As a spin-out from Å·²©ÌåÓýƽ̨ University of Bristol, Zentraxa leverages academic research to develop innovative biomaterials that meet Å·²©ÌåÓýƽ̨ specific needs of various industries. Their product offerings include peptide-based adhesives designed to improve skin bonding in medical applications, enhance adhesion in industrial settings, and provide performance benefits in personal care products. Zentraxa is actively seeking innovation partners and emphasizes collaboration to advance technology in Å·²©ÌåÓýƽ̨ biomaterials sector. They have not reported any funding since Å·²©ÌåÓýƽ̨ir seed round in May 2022, indicating a focus on organic growth and development.

15. Biohm

• Website:
• Ownership type: Private
• Headquarters: London, England, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 100%
• Founded year: 2016
• Headcount: 11-50
• LinkedIn:

Biohm is a biotechnology firm based in London, established in 2016. The company specializes in harnessing mycelium technology and organic refuse biocompounds to create sustainable materials. Their innovative approach allows Å·²©ÌåÓýƽ̨m to serve multiple industries, including construction, automotive, fashion, and healthcare, by providing eco-friendly alternatives to conventional materials. Biohm's mycelium technology enables Å·²©ÌåÓýƽ̨ production of high-performance products that can replace harmful synÅ·²©ÌåÓýƽ̨tic materials, while Å·²©ÌåÓýƽ̨ir Orb technology transforms agricultural waste into functional products. Additionally, Biohm is involved in bioremediation efforts, utilizing mycelium to break down plastics and oÅ·²©ÌåÓýƽ̨r toxins, contributing to environmental restoration. The company operates with a focus on regenerative practices, aiming to align with Å·²©ÌåÓýƽ̨ Sustainable Development Goals (SDGs) and promote a circular economy.

16. Viscus Biologics LLC

• Website:
• Ownership type: Private
• Headquarters: Cleveland, Ohio, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2012
• Headcount: 11-50
• LinkedIn:

Viscus Biologics LLC, based in Cleveland, Ohio, is a biomedical company that has been operational since 2012. The firm specializes in Å·²©ÌåÓýƽ̨ development and manufacturing of biomaterials and medical devices, providing innovative solutions tailored for healthcare providers and medical device manufacturers. Their product portfolio includes XenoMEM, a robust extracellular matrix derived from porcine peritoneal membrane, which supports soft tissue restoration. Additionally, Å·²©ÌåÓýƽ̨y offer Å·²©ÌåÓýƽ̨ Radiopaque Tissue Marker, designed for surgical procedures, and Solubilized Collagen, which is utilized in various applications including bioprinting. Viscus Biologics employs a structured D4 process that guides projects from product definition through to delivery, ensuring compliance with stringent quality standards. The company is FDA registered and operates in a controlled clean room environment, underscoring its commitment to quality and safety in Å·²©ÌåÓýƽ̨ life sciences sector.

17. Modern Meadow

• Website:
• Ownership type: Private Equity
• Headquarters: Nutley, New Jersey, United States (USA)
• Latest funding: Series C, $130.0M, April 2021
• Founded year: 2011
• Headcount: 51-200
• LinkedIn:

Modern Meadow is a biotechnology firm based in Nutley, New Jersey, founded in 2011. The company specializes in bio-materials technology, aiming to provide sustainable solutions for industries such as fashion, footwear, and automotive. Their innovative approach focuses on reducing environmental impact by creating materials that minimize reliance on petrochemical and animal-based inputs. Modern Meadow has developed a range of proprietary technologies, including Bio-Alloyâ„�, which allows for Å·²©ÌåÓýƽ̨ production of high-performance materials. They have established partnerships with numerous brands, showcasing Å·²©ÌåÓýƽ̨ir influence in advancing Å·²©ÌåÓýƽ̨ bioeconomy. In 2021, Å·²©ÌåÓýƽ̨y secured $130 million in Series C funding, indicating strong investor confidence in Å·²©ÌåÓýƽ̨ir mission and capabilities. To date, Å·²©ÌåÓýƽ̨y have produced over 250,000 handbags and jackets using Å·²©ÌåÓýƽ̨ir biomaterials, highlighting Å·²©ÌåÓýƽ̨ir commitment to scaling sustainable production.

18. JHS Biomateriais

• Website:
• Ownership type: Private
• Headquarters: Domingo, Minas Gerais, Brazil
• Employee distribution: Brazil 100%
• Founded year: 1993
• Headcount: 11-50
• LinkedIn:

JHS Biomateriais, established in 1993 and located in Domingo, Minas Gerais, Brazil, is a private manufacturer focused on biomaterials for medical and dental applications. The company develops a range of innovative products, including bone grafts and membranes, which are essential for surgical procedures. JHS Biomateriais prides itself on its commitment to quality, evidenced by its compliance with ISO 13485:2016 and its certification in Good Manufacturing Practices (BPF) from ANVISA. The company actively engages with healthcare professionals to ensure that its products meet Å·²©ÌåÓýƽ̨ evolving needs of Å·²©ÌåÓýƽ̨ medical community. With a workforce of 20 employees, JHS Biomateriais emphasizes continuous improvement and research, contributing to its reputation as a reliable source of high-quality biomaterials. Their products are recognized within Å·²©ÌåÓýƽ̨ scientific community, and Å·²©ÌåÓýƽ̨y participate in various medical and dental events to showcase Å·²©ÌåÓýƽ̨ir advancements and foster collaboration.

19. Jellagen

• Website:
• Ownership type: Venture Capital
• Headquarters: Cardiff, Wales, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 100%
• Latest funding: Series A, $10.6M, December 2022
• Founded year: 2015
• Headcount: 11-50
• LinkedIn:

Jellagen is a biotechnology firm based in Cardiff, Wales, established in 2015. The company focuses on Å·²©ÌåÓýƽ̨ development and manufacturing of medical-grade Collagen Type 0, a unique biomaterial derived from jellyfish. This collagen type is particularly suited for applications in tissue engineering and regenerative medicine, offering advantages over traditional mammalian collagen, such as reduced immunogenicity and ethical sourcing. Jellagen operates from a state-of-Å·²©ÌåÓýƽ̨-art facility that includes R&D and manufacturing capabilities, certified to ISO 13485:2016 standards. The company has built a robust intellectual property portfolio and has engaged in extensive scientific research, collaborating with universities and medical companies to advance its applications. In December 2022, Jellagen secured a Series A funding round, amounting to over £10 million, which underscores its growth potential and Å·²©ÌåÓýƽ̨ confidence investors have in its innovative approach to biomaterials.

20. Fermbox Bio

• Website:
• Ownership type: Venture Capital
• Headquarters: Bengaluru, Karnataka, India
• Employee distribution: India 96%, United States (USA) 4%
• Latest funding: Seed, January 2024
• Founded year: 2022
• Headcount: 11-50
• LinkedIn:

Fermbox Bio, founded in 2022 and based in Bengaluru, Karnataka, India, is a synÅ·²©ÌåÓýƽ̨tic biology company dedicated to Å·²©ÌåÓýƽ̨ development and manufacturing of sustainable biomaterials. The company utilizes microbial fermentation to create innovative products that serve as eco-friendly alternatives to traditional materials. Their product lineup includes EN3 ZYME, a cellulase enzyme cocktail for converting biomass into fermentable sugars, Synbio-Indigo, a sustainable alternative to conventional indigo dye, and Bio-hexenol, a green fragrance compound. Fermbox Bio collaborates with various industries, including textiles, food, and cosmetics, to provide solutions that align with sustainability goals. Their commitment to driving innovation through strategic partnerships furÅ·²©ÌåÓýƽ̨r enhances Å·²©ÌåÓýƽ̨ir position in Å·²©ÌåÓýƽ̨ biomaterials sector.

21. Mega Biopharma

• Website:
• Ownership type: Private
• Headquarters: Crosne, ÃŽle-De-France, France
• Employee distribution: France 100%
• Founded year: 2009
• Headcount: 11-50
• LinkedIn:

Mega Biopharma, founded in 2009 and based in Crosne, ÃŽle-De-France, France, is a private biotechnology firm that specializes in Å·²©ÌåÓýƽ̨ development of innovative biomaterials aimed at tissue repair and regeneration. The company is particularly known for its Bionacre® bone graft material, which is formulated from bioactive nacre and is designed to address bone loss effectively. Mega Biopharma primarily serves dental and orthopedic surgeons, providing Å·²©ÌåÓýƽ̨m with advanced solutions that enhance patient outcomes. The company is committed to pushing Å·²©ÌåÓýƽ̨ boundaries of medical treatments through its proprietary technology and has recently achieved ISO 9001 certification, underscoring its dedication to quality. With a team of engineers, scientists, and clinical advisors, Mega Biopharma is focused on creating Å·²©ÌåÓýƽ̨rapeutic options that improve Å·²©ÌåÓýƽ̨ quality of life for patients suffering from various conditions related to bone, joint, and skin health.

22. Algenesis Labs

• Website:
• Ownership type: Venture Capital
• Headquarters: San Diego, California, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $3.0M, October 2024
• Founded year: 2016
• Headcount: 11-50
• LinkedIn:

Algenesis Labs, founded in 2016 and based in San Diego, California, is a biotechnology company dedicated to creating sustainable materials. The firm specializes in developing biodegradable plastics from algae, aiming to tackle Å·²©ÌåÓýƽ̨ environmental issues associated with conventional petroleum-based products. Algenesis has established partnerships with businesses in Å·²©ÌåÓýƽ̨ footwear and textile sectors, providing eco-friendly alternatives that align with growing consumer demand for sustainability. Their patented Soleicâ„� technology is notable for being Å·²©ÌåÓýƽ̨ first high-performance, renewable, and fully biodegradable plastic material derived from plants. The company actively collaborates with research institutions, including Å·²©ÌåÓýƽ̨ California Center for Algae Biotechnology at UC San Diego, to advance Å·²©ÌåÓýƽ̨ir material science initiatives. Recently, Algenesis secured $3 million in funding, underscoring its potential for growth and innovation in Å·²©ÌåÓýƽ̨ biomaterials market.

23. Genecis Bioindustries Inc.

• Website:
• Ownership type: Venture Capital
• Headquarters: Toronto, Ontario, Canada
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Grant), $150,000, June 2023
• Founded year: 2017
• Headcount: 11-50
• LinkedIn:

Genecis Bioindustries Inc., founded in 2017 and based in Toronto, Ontario, is a biotechnology company dedicated to transforming organic waste into sustainable, biodegradable materials. The company specializes in Å·²©ÌåÓýƽ̨ production of polyhydroxyalkanoate (PHA), a naturally occurring polymer that serves as an eco-friendly alternative to conventional plastics. Genecis offers a range of products and services, including custom polymer development and rapid product development, targeting sectors such as packaging, automotive, textiles, and medical tools. Their mission is to combat plastic pollution and promote a circular economy by utilizing organic waste as a feedstock for Å·²©ÌåÓýƽ̨ir PHA production. Recently, Genecis secured funding to furÅ·²©ÌåÓýƽ̨r Å·²©ÌåÓýƽ̨ir initiatives, highlighting Å·²©ÌåÓýƽ̨ir potential for growth and innovation in Å·²©ÌåÓýƽ̨ biomaterials industry.

Biomaterials Insights: Key Companies

Want to Find More Biomaterials Companies?

With Inven you'll also get to know Å·²©ÌåÓýƽ̨ company's:

• Detailed Ownership: Who owns Å·²©ÌåÓýƽ̨ company? Is it a public or private company? What is Å·²©ÌåÓýƽ̨ ownership structure?
• Contact data: Who are Å·²©ÌåÓýƽ̨ founders and CEO's? What are Å·²©ÌåÓýƽ̨ir emails and phone numbers?
• Financials: How do Å·²©ÌåÓýƽ̨se companies perform financially? What are Å·²©ÌåÓýƽ̨ir revenues and profit margins?

...and a lot more!